Stock data

北極星藥業-KY (6550)

北極星藥業-KY is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$6.30M, down 52.2% from a year earlier. EPS over the last four quarters totals -NT$4.70.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 北極星藥業-KY in Insightr